| Identification | Back Directory | [Name]
ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2 | [CAS]
112955-31-4 | [Synonyms]
PTHrP (1-34) amide
1-34-Human PTHrP amide
Hypercalcemia MalignancyFactor (1-34)
PTH-RP (HUMAN, 1-34 AMIDE) (RAT, MOUSE)
Parathyroid hormone-related protein (1-34) Amide
HYPERCALCEMIA OF MALIGNANCY FACTOR*FRAGM ENT 1-34 AM
pTH-Related Protein (1-34) aMide (huMan, Mouse, rat)
Humoral Hypercalcemic Factor (hHCF)(1-34)-NH2 (Human)
PARATHYROID HORMONE RELATED PROTEIN (HUMAN, 1-34 AMIDE) (RAT, MOUSE)
Hypercalcemia of malignancy factor fragment 1-34 amide human >=97% (HPLC)
HypercalceMia of Malignancy Factor (1-34) aMide (huMan, Mouse, rat), pTHrP (1-34) aMide (huMan, Mouse, rat)
ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2
Parathyroid hormone-related protein (1-34) Amide, PTHrP (1-34) amide, Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 | [Molecular Formula]
C180H288N58O47 | [MDL Number]
MFCD00081711 | [MOL File]
112955-31-4.mol | [Molecular Weight]
4016.57 |
| Chemical Properties | Back Directory | [storage temp. ]
−20°C | [Sequence]
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 |
| Hazard Information | Back Directory | [Uses]
pTH-Related Protein (1-34) amide (human, mouse, rat) (Human PTHrP-(1-34)NH2) is a N-terminal fragments of PTHrP. pTH-Related Protein (1-34) amide (human, mouse, rat) induces hypercalcemia, and can be used for research of humoral hypercalcaemia of malignancy[1]. | [References]
[1] Horiuchi N, et al. A 7-34 analog of the parathyroid hormone-related protein has potent antagonist and partial agonist activity in vivo. Bone Miner. 1991 Mar;12(3):181-8. DOI:10.1016/0169-6009(91)90031-t
[2] McFarlane DR, et al. FTIR spectroscopy study of PTHrP(1-34) involved in humoral hypercalcaemia of malignancy. Biochim Biophys Acta. 1993 Mar 5;1162(1-2):187-94. DOI:10.1016/0167-4838(93)90146-i |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|